KNSA: Kiniksa Pharmaceuticals Ltd - Class A
今日KNSA汇率已更改-3.18%。当日,交易品种以低点77.90和高点80.43进行交易。
关注Kiniksa Pharmaceuticals Ltd - Class A动态。实时报价将帮助您快速应对市场变化。通过在不同的时间周期之间切换,您可以按分钟、小时、天、周和月监控汇率趋势和动态。使用这些信息来预测市场变化并做出明智的交易决策。
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
KNSA新闻
- TGTX Stock Outperforms 95% of Stocks. Here's Why.
- Three Biotech Stocks Stick Out With Their Stellar Charts
- Kiniksa's Sales Are Expected To Decline — Why That's All According To Plan
- KNSA Q2 Earnings Call Backs Higher ARCALYST Sales Outlook
- Kiniksa Pharmaceuticals International, plc 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:KNSA) 2026-07-31
- Stock Market Rises Amid Apple, Amazon, Meta, Microsoft Earnings, Soaring Yields: Weekly Review
- MDGL Stock Down Despite Q2 Beat, MASH Drug Drives Top-Line Y/Y Growth
- Teva Q2 Earnings Lag Estimates, 2026 Revenue View Raised, Stock Rises
- Earnings Estimates Rising for Kiniksa Pharmaceuticals International, plc (KNSA): Will It Gain?
- Alkermes Q2 Earnings Break Even, Revenues Beat Estimates, Stock Down
- Kiniksa Pharmaceuticals International, plc (KNSA) Q2 Earnings Match Estimates
- EU Clears AZN's Etcamah Combo for First-Line ER-Positive Breast Cancer
- Zacks.com featured highlights include American Outdoor Brands, Cimpress, National Energy Services Reunited, CTO Realty Growth and Kiniksa Pharmaceuticals International
- PFE's Talzenna sNDA Gets FDA Priority Tag in Wider Prostate Cancer Use
- Community Health Q2 Loss Wider Than Expected, 2026 View Lowered
- Repligen to Expand Cell Therapy Capabilities With BioLife Buyout
- 5 Stocks With Recent Price Strength Despite Recent Market Volatility
- NKTR Up on Start of Phase III Program on Rezpeg for Atopic Dermatitis
- Recent Price Trend in Kiniksa Pharmaceuticals International, plc (KNSA) is Your Friend, Here's Why
- Profitable Biotechs Strut Their Stuff As Stock Market Stumbles
- Eli Lilly to Boost Neuroscience Pipeline With AtaiBeckley Buyout
- UnitedHealth Tops Q2 Earnings on Cost Control, Raises '26 Outlook
- ATAI Stock Soars on Reports of Potential Acquisition by Eli Lilly
- AZN Inks Deal With Dizal to In-License Rights to Lung Cancer Drug
常见问题解答
KNSA股票今天的价格是多少?
Kiniksa Pharmaceuticals Ltd - Class A股票今天的定价为77.91。它在77.90 - 80.43范围内交易,昨天的收盘价为80.47,交易量达到964。KNSA的实时价格图表显示了这些更新。
Kiniksa Pharmaceuticals Ltd - Class A股票是否支付股息?
Kiniksa Pharmaceuticals Ltd - Class A目前的价值为77.91。股息政策取决于公司,而投资者也会关注96.52%和USD。实时查看图表以跟踪KNSA走势。
如何购买KNSA股票?
您可以以77.91的当前价格购买Kiniksa Pharmaceuticals Ltd - Class A股票。订单通常设置在77.91或78.21附近,而964和-2.33%显示市场活动。立即关注KNSA的实时图表更新。
如何投资KNSA股票?
投资Kiniksa Pharmaceuticals Ltd - Class A需要考虑年度范围35.20 - 82.94和当前价格77.91。许多人在以77.91或78.21下订单之前,会比较-0.49%和。实时查看KNSA价格图表,了解每日变化。
Kiniksa Pharmaceuticals Ltd - Class A股票的最高价格是多少?
在过去一年中,Kiniksa Pharmaceuticals Ltd - Class A的最高价格是82.94。在35.20 - 82.94内,该股波动显著,与相比有助于发现阻力位。使用实时图表跟踪Kiniksa Pharmaceuticals Ltd - Class A的绩效。
Kiniksa Pharmaceuticals Ltd - Class A股票的最低价格是多少?
Kiniksa Pharmaceuticals Ltd - Class A(KNSA)的最低价格为35.20。将其与当前的77.91和35.20 - 82.94进行比较,可以发现潜在的长期切入点。观看KNSA在图表上的实时走势以获取更多详细信息。
KNSA股票是什么时候拆分的?
Kiniksa Pharmaceuticals Ltd - Class A历史上曾经历过股票拆分。这些变化在公司行动后的、80.47和96.52%中可见。
- 前一天收盘价
- 80.47
- 开盘价
- 79.77
- 卖价
- 77.91
- 买价
- 78.21
- 最低价
- 77.90
- 最高价
- 80.43
- 交易量
- 964
- 日变化
- -3.18%
- 月变化
- -0.49%
- 6个月变化
- 59.49%
- 年变化
- 96.52%